We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002625:SZSEKuang-Chi Technologies Co., Ltd. Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥38.69

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kuang‑Chi Technologies is trading at a price that is dramatically above its discounted cash‑flow estimate, implying severe overvaluation despite a robust revenue growth rate of over 40% and a cash pile that dwarfs its modest debt. Its trailing P/E of more than 100× versus an industry average of around 30× and a price‑to‑book multiple exceeding 8× underline the pricing disconnect, while the company does not pay any dividend, eliminating income‑focused appeal. Fundamentally, the firm boasts healthy gross and operating margins, ample liquidity, and a low debt‑to‑equity profile, which could support future expansion in aerospace and defense.
On the technical side, the stock is below its 200‑day moving average and the 20‑day SMA sits under the 50‑day SMA, signalling a bearish momentum that is confirmed by a negative MACD histogram. RSI hovers near the midpoint, suggesting no immediate oversold condition, but volatility remains elevated at nearly 50% over the past month. Decreasing volume and a price hovering near the identified support level add to short‑term downside risk, while the broader market sentiment is marked by “Extreme Greed,” potentially inflating speculative buying.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price far exceeds intrinsic DCF estimate
  • bearish technical indicators (below SMA200, negative MACD)
  • high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong cash position and low debt
  • sustained revenue growth trajectory
  • valuation still stretched but potential for price correction

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • strategic exposure to China’s aerospace and defense sector
  • robust operating margins and cash generation
  • expected alignment of price with fundamentals over time

Key Metrics & Analysis

Financial Health

Revenue Growth40.30%
Profit Margin32.45%
P/E Ratio117.2
ROE7.56%
ROA4.07%
Debt/Equity0.31
P/B Ratio8.7
Op. Cash FlowCN¥531.8M
Free Cash FlowCN¥525.6K
Industry P/E30.6

Technical Analysis

TrendBearish
RSI49.7
SupportCN¥34.11
ResistanceCN¥43.39
MA 20CN¥38.66
MA 50CN¥39.36
MA 200CN¥45.38
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥2.15
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.22
Volatility48.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.